Earlier:
Earlier:
Most Popular
Sponsored
Sun Pharma buys Organon for $11.75B cash deal. Organon's $14/share price offers 24% premium. Combined revenue $12.4B.
JEPI offers 8%+ yield with low volatility, outperforming in down markets but lagging bull runs. Reconsider for income.
Cint jumps 32% on private buyout offer, highlighting AI disruption's impact on tech valuations.
NFTs rally 15-20% on demand surge; Punks hit 31 ETH, BAYC near 10 ETH. Bitcoin ETFs see $813M inflows.
LKFN's EPS beat, but revenue missed. TBVPS growth is accelerating, dividend up 4%. Buy?
Adidas stock up 2% on marathon records, but YTD down 18% amid tariff/Mideast risks.
Iran talks stall, oil jumps 5%. S&P 500 futures dip as traders eye earnings & geopolitical risk.
Sponsored
Must Read